The Scientist

» science publishing and disease/medicine

Most Recent

image: New Algerian Research Center

New Algerian Research Center

By | May 14, 2012

Algeria is set to build the first HIV/AIDS research center in Africa.

2 Comments

image: Approving

Approving

By | May 14, 2012

The FDA is on board with a proposal to speed the approval of experimental pharmaceuticals that show big treatment effects early in clinical testing.

0 Comments

image: Death by Lab-Acquired Infection?

Death by Lab-Acquired Infection?

By | May 8, 2012

A researcher dead from a meningococcal infection may have acquired it in his laboratory.

6 Comments

image: Gene Signaling by Remote

Gene Signaling by Remote

By | May 7, 2012

Nanoparticles in mice can be switched on to activate insulin production using a radio signal.

0 Comments

image: First Drug from GM Plant Approved

First Drug from GM Plant Approved

By | May 4, 2012

A human enzyme grown in carrot cells will treat patients with Gaucher disease.

10 Comments

image: Bruce Alberts to Leave Science

Bruce Alberts to Leave Science

By | May 4, 2012

Editor-in-chief Alberts plans to leave Science next March, after high-profile 5-year tenure.

0 Comments

image: Nervous Mice Get Worse Cancer

Nervous Mice Get Worse Cancer

By | May 3, 2012

Anxious mice are more likely to come down with aggressive skin cancer than those who show less stress on behavioral tests.

0 Comments

image: Opinion: Missing Methods

Opinion: Missing Methods

By | May 3, 2012

A lack of methodological detail in the published literature threatens the foundation of scientific discourse.

22 Comments

image: UK Going Open Access

UK Going Open Access

By | May 3, 2012

The United Kingdom government hatches a plan to provide free public access to government-funded research.

0 Comments

image: FDA Disputes Data Under-Reporting

FDA Disputes Data Under-Reporting

By | May 2, 2012

The FDA and NIH dispute reports that clinical trial data is being under-reported.

0 Comments

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham